Corcept Therapeutics Faces Class Action Over Relacorilant Clinical Trial Claims
Class action lawsuit filed against $CORP alleging executives made false statements about relacorilant's clinical strength and FDA approval prospects.
CORTsecurities fraudclass action lawsuit
